Malaysian Startup Eyes Commercialization of LabGrown Unagi
Cooper Companies Stock Wall Street Analysts Weigh In on Price Targets
Freedom Broker Upgrades Realty Income O to Buy Following Strong Q1 AFFO Performance
Tariffs Ease but Trust Gap Persists for Chinese Companies in US Market
Global Ship Lease Reports First Quarter 2026 Results Management Discusses Market Conditions and Fleet Utilization
IEA Report Global Electric Car Sales Surpass 20 Million in 2025 Signaling Shift in Energy Landscape
Unitil Corporation UTL Q1 2026 Earnings Modest EPS Beat Stock Edges Higher
RNTX Q1 2026 Earnings EPS Beats Estimates as Preclinical Stage Biotech Tightens Spending
WLTH Q1 2026 Earnings EPS Miss Widens as Costs Outpace Estimates
Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises
STRL Q1 2026 Earnings EPS Surges Past Estimates on Strong Execution
FCRX Q1 2026 Earnings Slight EPS Miss Reflects Stable but Unspectacular Quarter
Zillow Faces Headwinds as Shares Decline Over 1 Key Levels to Watch
Oracle Corporation ORCL Hovers Near Resistance Amid Modest Decline
Mustang Bio MBIO Edges Higher Biotech Stock Testing Key Resistance at 067
Kalaris Therapeutics KLRS Posts Modest Gain Holding Above Key Support
Lionheart Holdings CUB Consolidates at 1080 Key Levels Define the Next Move
MindWalk Holdings Corp HYFT Climbs 468 Testing Key Resistance at 188
Orla Mining ORLA Dips Over 2 as Resistance Holds Firm
SR Bancorp SRBK Holds Steady Near Support Amid Low Volume
M3Brigade Acquisition V Corp MBAV Holds Steady Near 1080 as SPAC Market Awaits Catalyst
Woodside Energy WDS Holds Steady Near 2175 Amid Mixed Energy Sector Sentiment
Gogoro Inc GGR Shows Modest Decline Amid Consolidation
Wheat Futures Retreat on Friday as Rally Pauses
OTEX Q1 2026 Earnings EPS Beats Estimates by 746 Shares Dip
RH RH Rallies 245 as Shares Test Resistance Near 149
TaskUs Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises
FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Edges Lower
EXK Q1 2026 Earnings EPS Smashes Estimates by Nearly 60 Stock Edges Lower
ASR Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Weigh
Cytek Biosciences Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment
FET Q1 2026 Earnings EPS Surprises to the Upside as Stock Pulls Back
HMY Q2 2016 Earnings Earnings Miss Highlights Operational Headwinds